Volume 18, Number 3—March 2012
CME ACTIVITY - Research
Community-associated Clostridium difficile Infections, Monroe County, New York, USA
Table 3
Exposure | No. (%) |
---|---|
Medication† | |
Antimicrobial drugs | 32 (76) |
Penicillins | 12 (31) |
Clindamycin | 7 (18) |
Cephalosporins | 5 (13) |
Quinolones | 5 (13) |
Macrolides | 4 (10) |
Sulfa | 3 (8) |
Metronidazole | 2 (5) |
H2 blockers | 1 (2) |
PPI | 11 (26) |
Health care† | |
None | 5 (12) |
Outpatient visit | 35 (83) |
Physician office | 29 (69) |
Dentist | 13 (31) |
Emergency department visit | 6 (14) |
Visited a hospital or LTCF | 9 (21) |
Health care–related job | 2 (5) |
*CA-CDI, community-associated Clostridium difficile infection; PPI, proton pump inhibitor; LTCF, long-term care facility.
†Multiple exposures could be reported in the 12 weeks before CDI.
Page created: February 23, 2012
Page updated: February 23, 2012
Page reviewed: February 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.